![Kenneth Sandstöm](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kenneth Sandstöm
Plus aucun poste en cours
Profil
Kenneth Sandstöm worked as a Principal at AKELA Pharma Oy and Leiras.
He also served as a Project Manager-Product Development at BBS-Bioactive Bone Substitutes Plc.
Anciens postes connus de Kenneth Sandstöm
Sociétés | Poste | Fin |
---|---|---|
AKELA Pharma Oy
![]() AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Corporate Officer/Principal | - |
Leiras
![]() Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Corporate Officer/Principal | - |
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
Sociétés cotées | 1 |
---|---|
BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
Entreprise privées | 2 |
---|---|
AKELA Pharma Oy
![]() AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Health Technology |
Leiras
![]() Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Health Technology |